149 related articles for article (PubMed ID: 27502743)
1. Breslow density is a novel prognostic feature in cutaneous malignant melanoma.
Rashed H; Flatman K; Bamford M; Teo KW; Saldanha G
Histopathology; 2017 Jan; 70(2):264-272. PubMed ID: 27502743
[TBL] [Abstract][Full Text] [Related]
2. Breslow Density Is a Novel Prognostic Feature That Adds Value to Melanoma Staging.
Saldanha G; Yarrow J; Pancholi J; Flatman K; Teo KW; Elsheik S; Harrison R; O'Riordan M; Bamford M
Am J Surg Pathol; 2018 Jun; 42(6):715-725. PubMed ID: 29462090
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of sentinel lymph node biopsy according to Breslow thickness for cutaneous melanoma.
Stiegel E; Xiong D; Ya J; Funchain P; Isakov R; Gastman B; Vij A
J Am Acad Dermatol; 2018 May; 78(5):942-948. PubMed ID: 29408526
[TBL] [Abstract][Full Text] [Related]
4. The Width of Invasion in Malignant Melanoma Is a Novel Prognostic Feature That Accounts for Outcome Better Than Breslow Thickness.
Saldanha G; Khanna A; O'Riordan M; Bamford M
Am J Surg Pathol; 2020 Nov; 44(11):1522-1527. PubMed ID: 32604169
[TBL] [Abstract][Full Text] [Related]
5. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
6. Cellular cohesion as a prognostic factor in malignant melanoma: a retrospective study with up to 12 years follow-up.
Roxanis I; Chow J
Mod Pathol; 2010 Apr; 23(4):502-10. PubMed ID: 20173731
[TBL] [Abstract][Full Text] [Related]
7. Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.
Svobodová S; Browning J; MacGregor D; Pollara G; Scolyer RA; Murali R; Thompson JF; Deb S; Azad A; Davis ID; Cebon JS
Eur J Cancer; 2011 Feb; 47(3):460-9. PubMed ID: 21115342
[TBL] [Abstract][Full Text] [Related]
8. 5-Hydroxymethylcytosine is an independent predictor of survival in malignant melanoma.
Saldanha G; Joshi K; Lawes K; Bamford M; Moosa F; Teo KW; Pringle JH
Mod Pathol; 2017 Jan; 30(1):60-68. PubMed ID: 27713424
[TBL] [Abstract][Full Text] [Related]
9. Predictors of mucosal melanoma survival in a population-based setting.
Altieri L; Eguchi M; Peng DH; Cockburn M
J Am Acad Dermatol; 2019 Jul; 81(1):136-142.e2. PubMed ID: 30296542
[TBL] [Abstract][Full Text] [Related]
10. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
11. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging.
Dodds TJ; Lo S; Jackett L; Nieweg O; Thompson JF; Scolyer RA
Am J Surg Pathol; 2018 Mar; 42(3):359-366. PubMed ID: 29240580
[TBL] [Abstract][Full Text] [Related]
14. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
Vollmer RT; Seigler HF
Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of microscopically measured invasive width versus macroscopic width in cutaneous melanoma shows the superiority of microscopic invasive width measurement.
Bamford M; Udensi L; Khanna A; O'Riordan M; Saldanha G
J Cutan Pathol; 2022 Jun; 49(6):536-542. PubMed ID: 35262956
[TBL] [Abstract][Full Text] [Related]
16. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
Crocetti E; Mangone L; Lo Scocco G; Carli P
Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
[TBL] [Abstract][Full Text] [Related]
17. The Relationship Between Epidermal Mitotic Density, Atypical Mitotic Figure Density, Breslow Depth, Ulceration, and Dermal Mitotic Rate in Cutaneous Melanoma: A Retrospective Cohort Study.
Marsch AF; McKee RM; Werbel T; Ruo B; Hinds BR
Int J Surg Pathol; 2021 Sep; 29(6):592-599. PubMed ID: 33624542
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
[TBL] [Abstract][Full Text] [Related]
19. Breslow thickness and (18)F-FDG PET-CT result in initial staging of cutaneous melanoma: Can a cut-off point be established?
Ortega-Candil A; Rodríguez-Rey C; Cano-Carrizal R; Cala-Zuluaga E; González Larriba JL; Jiménez-Ballvé A; Fuentes-Ferrer ME; Cabrera-Martín MN; Pérez-Castejón MJ; García García-Esquinas M; Lapeña-Gutierrez L; Carreras-Delgado JL
Rev Esp Med Nucl Imagen Mol; 2016; 35(2):96-101. PubMed ID: 26597332
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker.
Callender GG; Egger ME; Burton AL; Scoggins CR; Ross MI; Stromberg AJ; Hagendoorn L; Martin RC; McMasters KM
Am J Surg; 2011 Dec; 202(6):659-64; discussion 664-5. PubMed ID: 22137134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
